Stryker takes preferred equity stake in CMR Surgical for USD 400 million
- Stryker agreed to invest about USD 400 million in CMR Surgical through a preferred equity investment.
- Deal grants an exclusive option to acquire 100% of CMR Surgical’s outstanding equity in the future.
- Stryker will act as exclusive U.S. sales agent for CMR’s Versius surgical robotics portfolio.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stryker Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610120800OMX_____CNEWS_EN_GNW9843816_en) on October 12, 2026, and is solely responsible for the information contained therein.